Cargando…
Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis
Bone marrow fibrosis is the continuous replacement of blood‐forming cells in the bone marrow with excessive scar tissue, leading to failure of the body to produce blood cells and ultimately to death. Myofibroblasts are fibrosis‐driving cells and are well characterized in solid organ fibrosis, but th...
Autores principales: | Gleitz, Hélène FE, Kramann, Rafael, Schneider, Rebekka K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969225/ https://www.ncbi.nlm.nih.gov/pubmed/29570794 http://dx.doi.org/10.1002/path.5078 |
Ejemplares similares
-
Fibrosis driving myofibroblast precursors in MPN and new therapeutic pathways
por: Gleitz, Hélène F.E., et al.
Publicado: (2019) -
“ASXL1”-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms
por: Gleitz, Hélène F.E., et al.
Publicado: (2022) -
Isolation of human bone marrow stromal cells from bone marrow biopsies for single-cell RNA sequencing
por: Gleitz, Hélène F.E., et al.
Publicado: (2021) -
Still a burning question: the interplay between inflammation and fibrosis in myeloproliferative neoplasms
por: Gleitz, Hélène F.E., et al.
Publicado: (2021) -
S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
por: Gleitz, Hélène, et al.
Publicado: (2023)